MMP9 and hepatocellular carcinoma: Overexpression of PTPN13 up-regulated the epithelial marker E-cadherin and down-regulated mesenchymal markers such as Snail, Slug and Matrix metallopeptidase 9 (MMP9) [19], suggesting PTPN13 can inhibit EMT in HCC progression.